Essex Investment Management CO LLC Amicus Therapeutics, Inc. Transaction History
Essex Investment Management CO LLC
- $536 Million
- Q3 2024
A detailed history of Essex Investment Management CO LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Essex Investment Management CO LLC holds 268,743 shares of FOLD stock, worth $2.53 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
268,743
Previous 268,000
0.28%
Holding current value
$2.53 Million
Previous $2.66 Million
7.98%
% of portfolio
0.54%
Previous 0.53%
Shares
11 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
314MCall Options Held
516KPut Options Held
833K-
Vanguard Group Inc Valley Forge, PA28.8MShares$271 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$264 Million7.83% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$229 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA24MShares$226 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$218 Million3.72% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.64B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...